Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron

CEO David Ricks wants Eli Lilly’s upcoming obesity pill to be accessible to patients who need it, but the company still needs to pay for the next generation of obesity medicines to come after that.